Displaying drugs 6776 - 6800 of 7313 in total
Bucladesine
Experimental
Carumonam
Experimental
Reversin 121
Reversin 121 is a hydrophobic peptide chemosensitizer that can reverse P-glycoprotein-mediated multidrug resistance.
Experimental
UDP-6-sulfoquinovose
Experimental
JE-2147
Experimental
3'-phospho-5'-adenylyl sulfate
3'-phospho-5'-adenylyl sulfate is a key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process...
Experimental
Diguanosine-5'-Triphosphate
Experimental
Serine-3'-aminoadenosine
Experimental
Tretazicar
Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).
Investigational
cis-tetracosenoyl sulfatide
Experimental
Sulfatide
Any of a class of cerebroside sulfuric esters, they are found largely in the medullated nerve fibers and may accumulate in metachromatic leukodystrophy.
Experimental
Flovagatran
Investigational
PPI-1019
Apan (PPI-1019) is developed by Praecis Pharmaceuticals to treat Alzheimer's Disease.
Investigational
Rebimastat
Investigational
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
Experimental
Eribaxaban
Experimental
D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide
Experimental
GW-813893
Experimental
Displaying drugs 6776 - 6800 of 7313 in total